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Non-hematopoietic cells contribute to protective
tolerance to Aspergillus fumigatus via a TRIF pathway
converging on IDO
Antonella de Luca1, Silvia Bozza1, Teresa Zelante1, Silvia Zagarella1, Carmen D’Angelo1, Katia Perruccio1,
Carmine Vacca1, Agostinho Carvalho1,2, Cristina Cunha1, Franco Aversa1 and Luigina Romani1
Innate responses combine with adaptive immunity to generate themost effective form of anti-Aspergillus immune resistance. Whereas
the pivotal role of dendritic cells in determining the balance between immunopathology and protective immunity to the fungus is well
established, we determined that epithelial cells (ECs) also contributes to this balance. Mechanistically, EC-mediated protection
occurred through a Toll-like receptor 3/Toll/IL-1 receptor domain-containing adaptor-inducing interferon (TLR3/TRIF)-dependent
pathway converging on indoleamine 2,3-dioxygenase (IDO) via non-canonical nuclear factor-kB activation. Consistent with the high
susceptibility of TRIF-deficient mice to pulmonary aspergillosis, bone marrow chimeric mice with TRIF unresponsive ECs exhibited
higher fungal burdens and inflammatory pathology than control mice, underexpressed the IDO-dependent T helper 1/regulatory T cell
(Th1/Treg) pathway and overexpressed the Th17 pathway with massive neutrophilic inflammation in the lungs. Further studies with
interferon (IFN)-c, IDO or IL-17R unresponsive cells confirmed the dependency of immune tolerance to the fungus on the IFN-c/IDO/
Treg pathway and of immune resistance on the MyD88 pathway controlling the fungal growth. Thus, distinct immune pathways
contribute to resistance and tolerance to the fungus, to which the hematopoietic/non-hematopoietic compartments contribute through
distinct, yet complementary, roles.
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INTRODUCTION
Dendritic cells (DCs) orchestrate the adaptive immune responses to
Aspergillus fumigatus.1–3 The capacity of DCs to initiate different adapt-
ive immune responses to the fungus largely relied upon specialization
and cooperation between distinct DC subsets and the discriminative
recognition of fungal morphotypes by distinct innate recognition recep-
tors.4–6 Because of their heterogeneity and plasticity, DCs are central in
the early decision-making mechanisms that results in a given type of
immune response to the fungus and determine the balance between
immunopathology and protective immunity generated by the host–
fungus interaction.1 However, infectious or inflammatory conditions
can profoundly alter the functions of steady-state DC subsets and
recruit inflammatory-type DCs to the lung. This might be important
for clearing the pathogenic stimulus, but could at the same time lead to
immune pathology.7 In this regard, DCs expressing the enzyme indo-
leamine 2,3-dioxygenase (IDO), by means of activating regulatory T
cells (Tregs), help to tame overzealous and exaggerated inflammatory
responses in infection and allergy to the fungus8,9 and confer protective
tolerance in hematopoietic transplantation.6 As a matter of fact, IL-23
produced by inflammatory DCs and the T helper 17 (Th17) pathway,
which downregulate tryptophan catabolism, favored pathology and
served to accommodate the seemingly paradoxical association of
chronic inflammation with fungal persistence.10–12
No longer considered innocent bystanders,13 airway epithelial cells
(ECs) are central participants in innate and adaptive immune res-
ponses as well as mucosal inflammation and allergy.14 Through the
activation of Toll-like receptors (TLRs) by endogenous and exogenous
ligands, ECs may play a central role in determining the balance
between a state of ‘mucosal homeostasis’, as is required for optimal
organ function, and ‘mucosal injury’, leading to mucosal inflam-
mation and barrier breakdown.13 Recent evidence indicated that
ECs may also contribute to immunity to respiratory pathogens. ECs
provided protection against Mycobacterium tuberculosis via an inter-
feron (IFN)-c/IDO axis culminating in the inhibition of Th17 cell
responses.15 A. fumigatus conidia are internalized by ECs and, once
inside, some conidia traffic to late endosomes/lysosomes, where they
can germinate. This has lent to the credence that ECs may serve as
reservoirs for immune evasion.16,17 However, respiratory ECs also sense
germinating conidia through MyD88-dependent and -independent
pathways.18 Of interest, IDO overexpression from the airway ECs was
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found to restrain CD41 T-cell activation to the fungus, an activity that
was nevertheless dispensable in the presence of IDO-expressing DCs.19
In the present study, we assess the contribution of ECs to protective
immunity to Aspergillus and the possible mechanisms underlying this
activity in experimental models of pulmonary aspergillosis. We found
that ECs contribute to immunity to the fungus by providing protective
tolerance through a TLR3/Toll/IL-1 receptor domain-containing
adaptor-inducing IFN (TRIF)-dependent pathway converging on
IDO, a key regulator of the Th1/Treg versus Th17 pathway balance.
Because the MyD88 pathway mainly contributed to antifungal resist-
ance by restraining the fungal growth, our findings suggest that dis-
tinct immune pathways account for resistance and tolerance to the
fungus, to which the hematopoietic/non-hematopoietic compart-
ments contribute through distinct, yet complementary, roles.
MATERIAL AND METHODS
Mice
Female C57BL/6 and BALB/cmice, 8–10 weeks old, were purchased from
Charles River (Calco, Italy). Homozygous Tlr32/2, Tlr42/2, Myd882/2,
Trif2/2, Indo2/2(Indotm 1 Alm/J), Il17ra2/2 , Ifng2/2 , Ifnra12/2,
Il1r12/2 or Casp12/2 mice on a C57BL/6 background were bred under
specific pathogen-free conditions at the Animal Facility of Perugia
University (Perugia, Italy). Experiments were performed according to
the Italian Approved Animal Welfare Assurance A-3143-01.
Fungal strains, infections and treatments
The strain ofA. fumigatuswas obtained from a fatal case of pulmonary
aspergillosis at the Infectious Diseases Institute of the University
of Perugia. Viable conidia (.95%) were obtained by growth on
Sabouraud dextrose agar (Difco Laboratories, Detroit, MI, USA) sup-
plemented with chloramphenicol for 4 days at room temperature.
Swollen conidia were obtained as described.1 For infection, mice were
anesthetized by intraperitoneal (i.p.) injection of 2.5% avertin (Sigma-
Aldrich, St Louis, MO, USA) before instillation of a suspension of
23107 conidia/20 ml saline intranasally (i.n.). Fungi were suspended
in endotoxin-free (Detoxi-gel; Pierce, Rockford, IL, USA) solutions
(,1.0 EU/ml, as determined by the Limulus amebocyte lysate
method). Mice were monitored for fungal growth (colony-forming
unit (CFU)/organ, mean6SE) and histopathology (periodic acid-
Schiff (PAS) staining of lung tissue sections). Bronchoalveolar lavage
(BAL) was performed by cannulating the trachea and washing the
airways with 3 ml of phosphate-buffered saline (PBS) to collect the
BAL fluid. Total and differential cell counts were done by staining
BAL smears with May–Gru¨nwald Giemsa reagents (Sigma-Aldrich)
before analysis. At least 200 cells per cytospin preparation were
counted and the absolute number of each cell type was calculated.
Photographs were taken using a high-resolution Olympus DP71
microscope (Olympus, Milan, Italy). Mice were treated i.p. daily,
starting 3 days before and up to 3 days after the infection with PBS
or 20 mg/kg of a mixture of L-kynurenine, 3-hydorxykynurenine and
3-hydroxyanthranilic acid (Sigma-Aldrich). Treatment with 200 mg/
mouse of IL-17-neutralizing monoclonal antibodies (clone TC11-
18H10; PharMingen, San Diego, CA, USA)10 or isotype control anti-
body (rat IgG; Sigma-Aldrich) was done i.p. the day of and a day after
the infection.
Generation of bone marrow chimeras and hematopoietic stem cell
transplantation (HSCT)
Donor wild-type (WT) and knockout (KO) mice were euthanized
with CO2 asphyxiation and cervical dislocation, and femurs and tibias
were removed aseptically. Bone marrow was flushed with cold
Dulbecco’s modified Eagle’s medium supplemented with 10% heat-
inactivated fetal calf serum and 2 mM L-glutamine (Invitrogen Srl,
Milan, Italy). Cells were washed twice with PBS without calcium and
magnesium supplemented with 1% fetal calf serum. T-cell depletion
was obtained upon incubation of the cells with MicroBeads (Miltenyi
Biotec, Bergisch Gladbach, Germany) conjugated to rat antimouse
CD5 monoclonal antibodies (Ly-1; clone 53–7.3) for 15 min at 4 uC
followed bymagnetic sorting in a magnetic cell separator (CliniMACS
cell separation system; Miltenyi Biotec). Viable cells were counted in a
hemacytometer with a trypan blue exclusion assay. Recipient WT and
KO mice were irradiated with 9 Gy and reconstituted no later than
6 h after the last irradiation with 13106 T-repleted (chimeras) or
T-depleted (HSCT) cells by intravenous injection. Mice were given
sulfamethoxazole (150 mg/ml) and trimethoprim (30 mg/ml) in
drinking water for the first 3 weeks of reconstitution. HSCTmice were
infected i.n. a week later with Aspergillus conidia, while chimeras were
used no earlier than 4weeks after transplantation. Before use in experi-
ments, all mice were bled from the retro-orbital plexus, and the peri-
pheral blood lymphocytes were analyzed by reverse transcription-PCR
for the expression of Myd88, Trif, Ifng, Indo and Il17ra to assess the
degree of chimerism.
Cell isolation
For isolation of lung cells, lungs were aseptically removed and cut into
small pieces in cold medium. The dissected tissue was then incubated
inmedium containing collagenase XI (0.7mg/ml; Sigma-Aldrich) and
type IV bovine pancreatic DNase (30 mg/ml; Sigma-Aldrich) for 30–
45 min at 37 uC. The action of the enzymes was stopped by adding
10 ml of medium, and digested lungs were further disrupted by gently
pushing the tissue through a nylon screen. The single-cell suspension
was then washed and centrifuged at 200 g. Contaminating red blood
cells were lysed, and cells were then washed with PBS containing 0.5%
fetal calf serum, counted and incubated with fluorescein isothiocyanate
(FITC)-labeled GL3 (hamster anti-cd T-cell receptor; PharMingen)
followed by anti-FITC MicroBeads (Miltenyi Biotech) or with CD41
CD251 Regulatory T Cell Isolation Kit (Miltenyi Biotech) before mag-
netic cell sorting.10
EC purification, stimulation and treatment with small interfering
RNA (siRNA)
Lung ECs, at,99% expressing cytokeratin, on pan–cytokeratin anti-
body staining of cytocentrifuge preparations, and .90% viable on
trypan blue exclusion assay, were isolated as described.20 The average
yield of tracheal cells was 1.73105 cells/trachea (60.583105 (SD)).
ECs (106) were stimulated with resting or swollen conidia (1 : 1 ratio),
100 U IFN-c 10 mg/ml Zymosan, 10 mg/ml Poli(I:C), 10 mg/ml ultra-
pure lipopolysaccharide from Salmonella minnesota Re 595 (all from
Sigma-Aldrich), and 10 mg/ml ODN-CpG1 for 1 h (nuclear factor
(NF)-kB and IFN regulatory factor 3) or 18 h (IDO and cytokines).
ECs were seeded into 96-well plates and then siRNA was added in a
final concentration of 1 mM for 72 h according to the manufacturer’s
instructions (Dharmacon RNAi Technologies, Chicago, IL, USA). The
silencing effects of siRNAswere confirmed bywestern blotting. In vitro
experiments were done in the presence of 2% fetal bovine serum.
Flow cytometry
Flow cytometry analyses involving surface expression of T-cell receptor-
cd, CD4 and CD25 molecules have previously been described.10 Stains
were preblocked with FcBlock (antimouse CD16/CD32; PharMingen).
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Western blotting
Protein phosphorylation was assessed on ECs stimulated as above.
Blots of cells lysates were incubated with rabbit polyclonal anti-
bodies recognizing the anti-phospho-IKKa (Ser180)/-IKKb (Ser181)
rabbit antibodies (Cell Signaling Technology, Danvers, MA, USA)
were used for western blotting of phospho-IKKa and -IKKb. Blots
were developed with the Enhanced Chemiluminescence Detection
Kit (Amersham Pharmacia Biotech, Milan, Italy).1 Immunoblotting
for IDO was performed with rabbit polyclonal IDO-specific anti-
bodies on ECs after 18-h stimulation. The positive control consisted
of IDO-expressing MC24 transfectants and the negative control of
mock-transfected MC22 cells. Scanning densitometry was done on
a Scion Image apparatus (Scion Corp, Frederick, MD, USA). The
pixel density of bands was normalized against total proteins or
b-tubulin.
Kynurenine assay
Kynurenine concentrations in the supernatants of 18-h EC cultures
were measured by high-performance liquid chromatography.10
ELISA, ELISPOT and real-time PCR
The level of cytokines in culture supernatants (24 h) of ECs was deter-
mined by Kit ELISA (R&D System, Milan, Italy). The detection limits
of the assays were,10 for IL-12p70,,3 for IL-10,,30 for IL-23, and
,10 for IL-17A and IL-17F. Real-time RT-PCR was performed using
the iCycler iQ detection system (Bio-Rad, Hercules, CA, USA) and
SYBR Green chemistry (Finnzymes Oy, Espoo, Finland). Cells were
lysed and total RNA was extracted using RNeasy Mini Kit (Qiagen,
Milan, Italy) and was reverse transcribed with Sensiscript Reverse
Transcriptase (Qiagen) according to the manufacturer’s directions.
The PCRprimers were as described.1,21 Amplification efficiencies were
validated and normalized againstGapdh. The thermal profile for SYBR
Green real-time PCR was at 95 uC for 3 min, followed by 40 cycles of
denaturation for 30 s at 95 uC and an annealing/extension step of 30 s
at 60 uC. Each data point was examined for integrity by analysis of the
amplification plot. The mRNA-normalized data were expressed as
relative cytokine mRNA in stimulated cells compared to that of
mock-infected cells. Cytokine-producing cells were enumerated by
ELISPOT assay on purified CD41 cells as described.21 Results were
expressed as the mean number of cytokine-producing cells (6SE) per
104 cells, calculated using replicates of serial twofold dilutions of cells.
Statistical analysis
Data were analyzed by GraphPad Prism 4.03 program (GraphPad
Software, San Diego, CA, USA). Student’s t-test or analysis of variance
and Bonferroni’s test were used to determine the statistical signifi-
cance (P) of differences in organ clearance and in vitro assays. The
data reported are either fromone representative experiment out of two
to four independent experiments (western blotting and RT-PCR) or
pooled from three to five experiments, otherwise. The in vivo groups
consisted of 6–8 mice/group.
RESULTS
Trif2/2mice are highly susceptible to pulmonary aspergillosis and
develop pathogen-induced inflammation
We evaluated parameters of infection, inflammation and adaptive
immunity in Trif2/2 and mice with pulmonary aspergillosis.
Despite the ability of both strains to restrain the fungal growth even-
tually, the initial fungal growth was higher in the lung and brain of KO
than WT mice (Figure 1a). Inflammation and signs of parenchymal
damage were also greatly exacerbated in Trif2/2 mice, which failed
to resolve and showed the presence of numerous PAS-positive
cells within the epithelial layer. Confirming previous studies,4,22,23
Myd882/2 mice were not susceptible to infection and inflammation
(Figure 1b). The number of polymorphonuclear cells increased and
maintained elevated in the lung parenchyma and the BAL fluids (insets
of Figure 1b also showing numerous hyphae, arrows) of Trif2/2 as
compared to WT or Myd882/2 mice. Gene expression analysis of the
lung confirmed the higher andmore persistent inflammatory response
in Trif2/2 thanWT/Myd882/2 mice, as revealed by the higher mRNA
expression of Cxcl1, Cxcl2 and Mpo genes as well as genes for inflam-
matory cytokines, such as Il1a (Figure 1c). As expected, the levels of
Ifna and Ifnb1were instead lower in Trif2/2 thanWT/Myd882/2 mice
(Figure 1c). Tlr32/2 (manuscript in preparation) but not Tlr42/2
mice24mimicked the patterns of susceptibility to infection and inflam-
mation of Trif2/2 mice, a finding revealing a previously undefined,
crucial role for the TLR3/TRIF pathway in aspergillosis. The failure to
resolve inflammation was not secondary to a deficient conidiocidal
activity of lung cells either from naive or 3-day-infected mice (the %
conidiocidal activity ranged from 2362 to 5067 (WT), 2264 to 4868
(Trif2/2) and 2868 to 65612 (Myd882/2)). In vitro, the conidiocidal
activity of purified neutrophils from each type of naive mice was not
different (the % conidiocidal activity was 3564 for WT, 3266 for
Trif2/2or 4168 for Myd882/2 cells). Thus, the TLR3/TRIF pathway
is not required for the conidiocidal activity of lung effector cells but
unexpectedly protects from unintended inflammation.
The subverted innate inflammatory response to the fungus10 and
the requirement for TLR3/TRIF in the activation of tolerogenic DCs in
aspergillosis1 would predict altered adaptive Th/Treg cell responses in
Trif2/2 mice. This was indeed the case as shown by the results of Th/
Treg cell activation in response to the fungus. Consistent with the DC
cytokine profile in response to the fungus,1 the levels (gene expression
and protein production) of IL-12p70 were lower and those of IL-23
higher in Trif2/2 than WT/Myd882/2 mice (Figure 2a). Accordingly,
the production of IFN-c/IL-10 in the lung (Figure 2b) and the corres-
ponding Tbet/Foxp3-specific transcripts in the thoracic lymph nodes
(Figure 2c) were lower and those of IL-17A/IL-17F (Figure 2b) and the
Rorc transcript (Figure 2c) higher in Trif2/2 than WT/Myd882/2
mice.
Susceptibility to aspergillosis has been associated with the prevalent
expansion of a subset of cd TCR1 cells expressing IL-23R and pro-
ducing IL-17A over that of CD41CD251Foxp31 Tregs.10 We found
that cd1 cells producing IL-17A and expressing IL-23Rwere expanded
in Trif2/2 as compared to WT/Myd882/2 mice, whereas cd1 cells
producing IFN-c were lower (Figure 2d–f). In contrast, despite the
expansion of CD41CD251 T cells in Trif2/2 mice, these cells failed to
express the Foxp3, Icos and, partially, Ctla4 transcripts (Figure 2g). As
predicted by the histological findings, Th2 (Gata3/Il4/Il13) cell res-
ponses were also higher in Trif2/2 than WT mice and, accordingly,
Trif2/2 mice were more susceptible to fungal allergy than WT mice
(Supplementary Figure 1). Thus, similar to what described in candi-
diasis,21 and consistent with the role of the TRIF pathway in promot-
ing tolerogenic DCs in response to the fungus,1 TRIF deficiency is
associated with the impairment of Th1/Treg protective responses
and upregulation of inflammatory Th2/Th17 cell responses.
The TLR3/TRIF pathway activates IDO on ECs
We have already shown that the TLR3/TRIF pathway activates IDO in
lung DCs through the non-canonical NF-kB pathway1 and that IDO1
DCs conferred antifungal protection upon adoptive transfer into
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hematopoietic transplantation.6 We assessed IDO protein expression
and activation in the lung of WT, Trif2/2 and Myd882/2 mice in
infection as well as in ECs upon stimulation in vitro. Trif2/2 mice
failed to induce IDO as opposed to WT or Myd882/2 mice.
However, IL-17A neutralization restored IDO expression in Trif2/2
mice and increased it in WTmice (Figure 3a). These data point to the
opposing activity of the TRIF and IL-17 pathways on IDO expression
and confirm previous results obtained in experimental candidiasis21
and M. tuberculosis infection.15 Paralleling the in vivo data, IDO
activation was observed in ECs from WT and Myd882/2 but not
Trif2/2 mice upon IFN-c stimulation, as revealed by protein express-
ion and kynurenine production (Figure 3b). The failure of resting
conidia to activate IDO in ECs (Figure 3b), prompted us to search
for microbial stimuli that would induce IDO in ECs. We found that
swollen conidia and selected TLR ligands, Poli(I:C) and ODN-CpG,
but not others, zymosan or lipopolysaccharide, promoted IDO pro-
tein expression in ECs (Figure 3c). Thus, IDO activation in ECs in
response to Aspergillus occurs through a TLR3/TRIF pathway. Further
Figure 1 Trif2/2 mice are highly susceptible to pulmonary aspergillosis and develop pathogen-induced inflammation. Mice were infected i.n. with live Aspergillus
conidia. (a) Fungal growth (CFU6SE). (b) Lung histology (PAS staining) and BAL morphometry (% PMN or % MNC) at different dpi. P, Trif2/2 versus WT mice. (c)
Inflammatory chemokine and cytokine gene expression in the lung by real-time RT-PCR. Note the sustained inflammatory cell recruitment in lungs and BAL
(May–Gru¨nwald Giemsa staining in the inset) in Trif2/2 mice. Bars indicated magnifications. Day 0 indicates uninfected animals. Data are pooled from four
experiments or representative of two experiments (for histology). *P,0.05, **P,0.01, ***P,0.001, Trif2/2 versus WT mice. BAL, bronchoalveolar lavage; CFU,
colony-forming unit; dpi, days post-infection; i.n., intranasally; MNC,mononuclear cells; PAS, periodic acid-Schiff; PMN, polymorphonuclear cells; RT-PCR, PCRwith
reverse transcription; WT, wild-type.
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studies showed that, similar to what observed in DCs,1 IDO activation
in ECs occurred through non-canonical NF-kB, and not IFN regula-
tory factor 3, the two major pathways downstream TLR3 signaling.25
Despite the fact that both pathways were activated in response to
swollen conidia or Poli(I:C), the inhibition of non-canonical NF-kB
by siRNA prevented downstream IDO activation (Figure 3c). Thus,
germinating conidia are sensed in infection by ECs through a TLR3/
TRIF pathway culminating in IDO activation and production of type I
IFNs and IL-10 (Figure 3d).
The IL-17/Th17 pathway worsens and kynurenine ameliorates the
infection in Trif2/2 mice
Because the type I IFN pathway constrains Th17 differentiation, Th17-
mediated inflammation26 and prevents chronic lung damage in a
Figure 2 Trif2/2 mice upregulate Th17 responses and downregulate Treg responses. Mice were infected i.n. with live Aspergillus conidia. (a, b) Cytokine gene
expression in the lung at different dpi (RT-PCR). (c) Cytokine gene expression in CD41T cells from thoracic lymphnodes at 7 dpi (RT-PCR). (d) Absolute numbers of cd
TCR1 in the lung; (e) Il23r expression on purified cd TCR1 cells by real-time RT-PCR; (f) number of cd TCR1 cells producing IL-17A or IFN-c by ELISPOT assay. (g)
Percentage of CD41CD251 T cells in the lung at different dpi and Foxp3, Icos and Ctla4 gene expression by real-time RT-PCR. Data are pooled from three
experiments. *P,0.05, **P,0.01, ***P,0.001, Trif2/2 versus WT mice. dpi, days post-infection; IFN, interferon; i.n., intranasally; RT-PCR, PCR with reverse
transcription; Th17, T helper 17; WT, wild-type.
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Figure 3 The TLR3/TRIF pathway activates IDO on ECs. Mice were infected i.n. with live Aspergillus conidia and treated with 200 mg IL-17A-neutralizing antibody or
isotype control antibody the day of and a day after the infection. (a) IDO protein expression in the lung. IDO expression was analyzed by immunoblotting with rabbit
polyclonal IDO-specific antibody on whole cell lysates. The positive control consisted of IDO-expressing MC24 transfectants and the negative control of mock-
transfected MC22 cells. (b) IDO protein expression and kynurenines production in ECs purified from lungs of naive mice and stimulated in vitro with RC (1 : 1 ratio)
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respiratory fungal infection,27 and the inflammasome/IL-1bmediates
antifungal host defense28 as well as pulmonary inflammation and
fibrosis,29,30 we assessed the contribution of the defective type I
IFNs and the upregulated IL-1b production to susceptibility to asper-
gillosis by infecting mice lacking IFN-ab receptor 1 (Ifnra12/2),
which are incapable of responding to type I IFNs, as well Il1r12/2 or
Casp 12/2 mice, which fail to express the NLRP3 inflammasome-
dependent antifungal immunity.31 We found that, despite variable
levels of fungal growth in the lung, the tissue inflammatory pathology
and cell infiltration were not different in the different types of mice as
compared to WT mice (Figure 4a) and no evidence of upregulated
Th17 responses was observed in the draining thoracic lymph nodes
(data not shown). To explore whether, similar to what observed in
hyperinflamed mice highly susceptible to aspergillosis,10 IL-17A
blockade or exogenous supply of kynurenines would ameliorate the
course of the infection, we subjected Trif2/2 mice to treatment with
either IL-17A neutralizing antibody or exogenous kynurenines. We
found that the fungal growth was restrained, the neutrophil recruit-
ment in BAL and the levels of IL-17A in the lung decreased and those
of IL-10 increased upon IL-17A neutralization (Figure 4b). Similarly,
Figure 4 The IL-17/Th17 pathway worsens and kynurenines ameliorate the infection in Trif2/2mice. (a) Fungal growth (CFU6SE) and lung histology (PAS staining) in
Ifnra12/2, Il1r12/2 or Casp12/2 mice 4 days after the i.n. infection with live Aspergillus conidia. Bars indicated magnifications. (b) Fungal growth (CFU6SE), BAL
morphometry (%PMN or %MNC) (at 3 days after the infection) and cytokine production in mice infected as above and treated i.p. with 200 mg IL-17A-neutralizing or
isotype control antibody the day of and a day after the infection. (c) Fungal growth (CFU6SE), lung histology (PAS staining) and IL-17A production in infected mice
treated daily, from 3 days before to 3 days after the infection, with PBS or 20 mg/kg of a mixture of L-kynurenine, 3-hydroxykynurenine and 3-hydroxyanthranilic acid.
Assays were a day after the last kynurenins treatment. Bars indicatedmagnifications. Data are pooled from two experiments. P, KO versusWTmice and treated versus
untreated mice. BAL, bronchoalveolar lavage; CFU, colony-forming unit; dpi, days post-infection; i.n., intranasally; i.p., intraperitoneal; KO, knockout; MNC, mono-
nuclear cells; PAS, periodic acid-Schiff; PBS, phosphate-buffered saline; PMN, polymorphonuclear cells; Th17, T helper 17; WT, wild-type.
or 100 U IFN-c for 18 h. (c) IDO expression (immunoblotting) in ECs from C57BL/6 mice stimulated with RC, SC or TLR ligands for 18 h. IKKa, IKKb and IRF3
expressions bywestern blottingwere performed after 1 h stimulation with Poli(I:C). For siRNA, cells were incubatedwith 1 mMsiRNA for 72 hbefore 1 h stimulation with
Poli(I:C). The silencing effects of siRNAs were confirmed by western blotting. (d) Cytokine gene expression by RT-PCR in Poli(I:C)-stimulated cells for 18 h. Scanning
densitometry was done on a Scion Image apparatus. The pixel density of bands was normalized against total proteins or b-tubulin. EC, epithelial cell; IDO, indoleamine
2,3-dioxygenase; IFN, interferon; i.n., intranasally; IRF3, IFN regulatory factor 3; RC, resting conidia; RT-PCR, PCR with reverse transcription; SC, swollen conidia;
siRNA, small interfering RNA; TLR3/TRIF, Toll-like receptor 3/Toll/IL-1 receptor domain-containing adaptor-inducing IFN.
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treatment with kynurenines decreased both the fungal growth and the
inflammatory response in Trif2/2 mice and, consistent with the apop-
totic activity on IL-17-producing cd1 cells,10 lowered IL-17A produc-
tion (Figure 4c). Together, these findings extend the therapeutic
effects of kynurenines in aspergillosis and confirm the contribution
of the upregulated IL-17/Th17 pathway in susceptibility to infection/
inflammation in condition of TRIF deficiency to which neither the
type I IFNs deficiency nor the inflammasome activation/IL-1 signaling
obviously contributes.
Mice with Trif2/2 non-hematopoietic cells upregulate Th17
responses and downregulate Th1/Treg responses to A. fumigatus
The finding that both DCs1 and ECs activate IDO in infection, and
IDO crucially regulates immunity and tolerance to the fungus,8–10 led
us to investigate the relative contribution of IDO activity in the
hematopoietic versus non-hematopoietic compartment in protective
immunity to the fungus. To this purpose, chimeric mice with TRIF
unresponsive hematopoietic or non-hematopoietic cells were assessed
for susceptibility to infection and inflammation. We found that TRIF
deficiency, particularly in ECs, greatly increased the susceptibility to
aspergillosis, both in terms of fungal growth and inflammatory res-
ponse in the lungs. These findings were not observed in mice with
MyD88 unresponsive cells on both compartments, in which no
inflammatory pathology were observed, despite evidence of fungal
outgrowth (Figure 5). These results would predict a division of labor
between the MyD88 and TRIF pathways in infection, namely, the
control of fungal growth by the former and the ensuing inflammation
by the latter. The results obtained in chimeric mice with cells of either
compartment simultaneously unresponsive to TRIF or MyD88 con-
firmed the crucial contribution of the MyD88 pathway to the control
of fungal growth and the contribution of the TRIF pathway, particu-
larly on non-hematopoietic cells, to the control of the inflammatory
response. The fungal growth and the inflammatory response were
indeed higher in mice with TRIF unresponsive non-hematopoietic
cells as compared to mice with TRIF unresponsive hematopoietic cells
(Figure 5), a finding suggesting the ability of TRIF responsive non-
hematopoietic cells to compensate for the lack of TRIF in hematopoi-
etic cells.
Further experiments in an experimental model of allogeneic T cell-
depleted hematopoietic transplantation (HSCT)2 confirmed that
TRIF deficiency in either donor or recipient cells was associated with
a worsening infection characterized by a limited fungal growth
(Figure 6a) but an exaggerated inflammatory response (Figure 6b),
increased IL-17A expression and decreased IFN-c/IL-10 responses in
the lung (Figure 6c). The finding that Foxp3 expression was lower in
condition of both donor and recipient TRIF deficiencies (Figure 6c),
further supports the contribution of the TRIF pathway to the activa-
tion of tolerogenic responses to the fungus. As a matter of fact, IDO
protein expression was lower in the lung of mice, particularly in con-
dition of recipient TRIF deficiency (data not shown). Confirming the
Figure 5 Bone marrow chimeric mice with Trif2/2 non-hematopoietic cells are highly susceptible to Aspergillus fumigatus infection and inflammation. Mice were
infected i.n. with liveAspergillus conidia. (a) Fungal growth (CFU6SE) and lung histology (PAS staining) in bonemarrow chimericWT and KOmice, at 3 dpi. DonorWT
and KOmice received 13106 viable bone marrow cells, 4 weeks before the infection. Note the increased susceptibility to aspergillosis, in terms of both fungal growth
and the inflammatory response in the lung of chimeric mice with TRIF unresponsive non-hematopoietic cells as opposed toMyD88 unresponsive cells. Bars indicated
magnifications. Data are representative of one experiment out of three.P, KORWT,WTRKO, KORKOversusWTRWTmice. CFU, colony-forming unit; dpi, days post-
infection; i.n., intranasally; KO, knockout; PAS, periodic acid-Schiff; TRIF, Toll/IL-1 receptor domain-containing adaptor-inducing interferon; WT, wild-type.
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findings of chimericmice, theMyD88 pathwaywasmainly responsible
for the control of fungal growth in both donor and recipient cells
(Figure 6a) and, interestingly, of IL-17A production (Figure 6c).
The IFN-c/IDO and IL-17R pathways differently contribute to
immune protection to A. fumigatus in hematopoietic
transplantation
To confirm the pivotal contribution of IDO in infection, we evaluated
parameters of infection, inflammation and Th cytokine production in
condition in which either donor or recipient cells were deficient for
IDO. Given the antagonistic activity of IFN-c and IL-17 on IDO
activation,10,11 we also comparatively used donors or recipients defi-
cient in IFN-c or IL-17R. Deficiency of IDO greatly contributed to
susceptibility to the infection in terms of increased fungal growth
(Figure 6d), inflammatory pathology (Figure 6e) and decreased
IFN-c/IL-10 production (Figure 6f), particularly in recipient mice.
Similar results were obtained with IFN-c KO recipient mice
(Figure 6d–f). In contrast, IL-17R deficiency, particularly in donor
cells, was associated with increased fungal growth but not inflammat-
ory response (Figure 6d and e). While the production of IL-10 was
unaffected, a decreased IFN-c production was observed in condition
of IL-17R deficiency (Figure 6f), a finding consistent with the Th1-
supporting role of the IL-17R signaling in fungal infections.32 Of
interest, the finding that the fungal growth was also higher in IL-
17R KO recipients as compared to controls indicates a role for recipi-
ent IL-17A in the control of fungal growth.
DISCUSSION
This study has revealed a previously unappreciated role for ECs in
aspergillosis, namely, the contribution of ECs to protective immunity
to Aspergillus through a TLR3/TRIF-dependent pathway converging
on IDO. We provide the direct evidence that ECs must be able to
induce IDO for the proper control of the infection and the associated
inflammatory response. Tryptophan metabolites and IDO represent
not only effector host defense pathways, but also a means of balancing
the generation of Th17 and Tregs.10,11 Tregs and IL-17-producing T
cells mediate opposing responses in aspergillosis, as clearly shown in
mice highly susceptible to aspergillosis where the augmentation of IL-
17-driven inflammation occurred concomitantly with the reduction
of anti-inflammatory Treg responses, resulting in excessive inflam-
mation.10 A reciprocal antagonistic relationship was found between
IDO and the Th17 pathway, with IDO inhibiting Th17 responses11,12
and IL-17 inhibiting IDO.12 Indeed, IDO1 DCs provided protective
tolerance to the fungus in experimental HSCT, by crucially affecting
the balance between immunity and tolerance in the lung.6 These data
are consistent with the role of IDO in hematology,33 its requirement
for the generation of Tregs34 and for protection against graft-versus-
host disease.35,36 However, allogeneic lung transplants expressing
recombinant IDO in endothelial cells and ECs dramatically reduced
acute cellular rejection37 and ECs provided protection against M.
tuberculosis via an IFN-c/IDO axis culminating in the inhibition of
Th17 cell responses.15 We found here that ECs contribute to the
immunoregulatory function of IDO in vivo and may compensate for
the lack of IDO on hematopoietic cells. This may accommodate the
recent finding by Paveglio et al.19 showing the superior role of
IDO1DCs in contributing to allergic airway inflammation. ECs activ-
ate IDO via TLR3, which is abundantly expressed both intracellularly
and on the cell surface of ECs,38 and IFN-c to which ECs also
respond.39 The failure to activate IDO likely accounted for the high
levels of inflammation seen in Trif2/2 mice, as proved by the immu-
norestorative effects of exogenously administered kynurenines,
known to induce apoptosis of IL-17A1 cd1 cells.10 Although ECswere
found to induce Treg expansion,13,14,40 restrained CD41 T-cell expan-
sion in response to Aspergillus,19 and produce IL-10 (this study), the
therapeutic effects of kynurenines will undoubtedly cover IDO defi-
ciency also in DCs. As a matter of fact, the highly polarized Th2/Th17
responses seen inTrif2/2 mice are immunological features compatible
with the functional program activated in lung DCs by the TRIF path-
way.1 Interestingly, Poli(I:C) also has a direct costimulatory effect on
IFN-c1 cd1 cells,41 a finding suggesting that the protective effect of
the TLR3/TRIF pathway in infection could be achieved through mul-
tiple mechanisms.
The TLR3/IDO axis has been reported to act as an innate antiviral
defense.42 Irrespective of whether IDO itself may contribute to the
antimicrobial innate function of ECs, our data indicate an important
role for the MyD88 pathway in ECs in the control of fungal growth, a
finding suggesting the possible antifungal effector activity of ECs. In
this regard, despite the fact that airways ECs phagocytose Aspergillus
conidia,16,17 the ability of conidia to survive in ECs17 was taken to
indicate airways ECs as a possible fungus reservoir. More recently,
ECs were found to respond to Aspergillus conidia viaMyD88-depend-
ent and -independent pathways18 and by upregulating antimicrobial
peptides43,44 endowedwith antifungal activity.45 Thus, the production
of IL-17A, known to induce antimicrobial peptides,46 is of particular
interest and worth of further investigation.
Overall, the data of the present study shed light on pathways of
immune resistance and tolerance to the fungus that likely take place
in a hematopoietic transplantation setting. It appears that protective
tolerance to the fungus is achieved through a TLR3/TRIF-dependent
pathway activating Th1/Tregs via IDO expressed on both the hemato-
poietic/non-hematopoietic compartments. The MyD88 pathway
instead likely provides antifungal resistance, i.e., the ability to restrict
the fungal growth, likely through defensins and other effectormechan-
isms. However, the ability of mice to clear the fungus in the relative
absence of the MyD88 pathway,4,22,23 clearly indicates redundancies
and hierarchy in antifungal mechanisms of resistance. Ultimately, the
finding that both Candida albicans21 and A. fumigatus, two major
human fungal pathogens, exploit the TRIF-dependent pathway at
the interface with themammalian hosts, indicate that the combinator-
ial configuration of antifungal resistance and tolerance is an advant-
ageous option.
Several genetic polymorphisms in pattern recognition receptors,
most remarkably TLRs, have been described to influence susceptibility
to aspergillosis in distinct clinical settings.47–49 In addition to the
Figure 6 Trif2/2/Ifng2/2/Indo2/2 non-hematopoietic cells upregulate Th17 responses and downregulate Th1/Treg responses to Aspergillus fumigatus in hemato-
poietic transplantation. HSCTmice were infected i.n. withAspergillus live conidia a week later the infusion of 13106 viable T-depleted bonemarrow cells. (a, d) Fungal
growth (CFU6SE), (b, e) lung histology (PAS staining) and (c, f) cytokine/Foxp3 gene expression (RT-PCR in lung and TLN, respectively) at 3 dpi. Note the
unrestrained fungal growth in condition of MyD88 deficiency as well as the exaggerated inflammatory response, increased Il17a expression and decreased Ifng/
Il10/Foxp3 expression in condition of TRIF, IFN-c or IDO deficiency, particularly in recipient cells. Bars indicated magnifications. Representative of two experiments.
P, KORWT,WTRKO versusWTRWTmice. CFU, colony-forming unit; dpi, days post-infection; HSCT, hematopoietic stem cell transplantation; IDO, indoleamine 2,3-
dioxygenase; IFN, interferon; i.n., intranasally; KO, knockout; PAS, periodic acid-Schiff; RT-PCR, PCR with reverse transcription; Th, T helper; TLN, thoracic lymph
nodes; Treg, regulatory T cell; TRIF, Toll/IL-1 receptor domain-containing adaptor-inducing IFN; WT, wild-type.
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mechanistic insights regarding the TRIF/IDO function in the hemato-
poietic/non-hematopoietic compartments, the present study suggests
the utility of the TRIF/IDO genetic screening to identify patients at
high risk for aspergillosis and, whenever possible, for adequate donor
selection.
Note: Supplementary information is available on the Cellular &
Molecular Immunology website (http://www.nature.com/cmi/).
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